Gunzburg called the possible timing of the release of the vaccine against COVID-19 based on virus-like particles

“The first-second phase of clinical trials should take place in 3-3.5 months, and then we will look at the effectiveness,” RIA Novosti quotes Gunzburg.

According to him, “if everything goes well, the vaccine will be released into civilian circulation by autumn.”

Gunzburg also noted that the new coronavirus drug containing virus-like particles does not contain live virus.

Earlier, the Russian Ministry of Health approved the conduct of clinical trials of the first and second phases of testing a coronavirus vaccine containing virus-like particles.